Telix and radioisotope maker ITM merge in deal worth up to $2.35B

Positive

AI Analysis

Summary

Telix Pharmaceuticals is acquiring German radioisotope manufacturer ITM Isotope Technologies Munich for $1.65 billion upfront, with total deal value up to $2.35 billion, contingent on milestones tied to a recently rejected drug.

Outcome Details

Merger agreement with deal milestones contingent on a recently rejected drug

Importance:7/10

Sentiment:

0.50

acquisitionmergerradioisotopemanufacturingdrug rejection

Related Companies

$TLPPF

Read the original article

Published by Endpoints News on September 21, 2026 1:52 PM

Read Original